Delphi advisor to the sellers of Lideta Hälsovård
Delphi has advised the owners of the Lideta Group (”Lideta”) in connection with the divestment of the shares to Nordstjernan.
Delphi has advised the owners of the Lideta Group (”Lideta”) in connection with the divestment of the shares to Nordstjernan.
Lideta engages in primary care via 15 units in Stockholm and southern Sweden. The company has grown rapidly since it was founded in 2001 by Dr. Larsson. The company currently has 93,000 listed patients, 350 employees and sales of approximately SEK 500 million. Over the last few years, Lideta has grown through acquisitions and invested in various digital initiatives to increase the accessibility and efficiency of primary care.
The transaction is subject to approval from the relevant competition authorities, which is expected during the fourth quarter of 2017.
Delphi’s team mainly consisted of Fredrik Mörner (responsible partner) and Linn Strömberg.
Your consent means that we collect information about your device and how you use the website which is linked to what Google knows. You can withdraw your consent by, for example, clicking on “Manage cookies” in the footer at the bottom of the page or contacting us at privacy@delphi.se.
We also use necessary cookies that enable core functionality. We do not require your consent to use these cookies. You can read a detailed description on how we use cookies, how you can avoid our cookies and also how to withdraw your consent here. Our use of cookies also entails processing of your personal data. Advokatfirman Delphi Stockholm AB is the data controller and responsible for the processing, which you can read more about here. You will also find information about your rights in relation to our processing of your personal data, namely the right to withdraw your consent, the right to object to our processing, the right of access, the right to rectification, the right to erasure and restriction, the right to data portability and the right to lodge a complaint.